Variant report
Variant | nsv901466 |
---|---|
Chromosome Location | chr14:20656645-20707100 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:194)
- CpG islands (count:366)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr14:20687322-20687431 | H1-hESC | embryonic stem cell: | n/a | chr14:20687387-20687401 |
2 | BACH1 | chr14:20687217-20687569 | K562 | blood: | n/a | chr14:20687387-20687401 |
3 | CCNT2 | chr14:20677752-20678071 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr14:20683358-20683686 | HepG2 | liver: | n/a | chr14:20683523-20683534 |
5 | CEBPB | chr14:20667271-20667577 | Hela-S3 | cervix: | n/a | chr14:20667443-20667454 |
6 | CEBPB | chr14:20683384-20683692 | Hela-S3 | cervix: | n/a | chr14:20683523-20683534 |
7 | CEBPB | chr14:20668608-20668745 | K562 | blood: | n/a | n/a |
8 | CEBPB | chr14:20667315-20667616 | A549 | lung: | n/a | chr14:20667443-20667454 |
9 | CEBPB | chr14:20683466-20683657 | K562 | blood: | n/a | chr14:20683523-20683534 |
10 | CEBPB | chr14:20667315-20667568 | K562 | blood: | n/a | chr14:20667443-20667454 |
11 | CEBPB | chr14:20659063-20659394 | HepG2 | liver: | n/a | chr14:20659228-20659241 chr14:20659229-20659240 chr14:20659227-20659244 |
12 | CEBPB | chr14:20667283-20667629 | HepG2 | liver: | n/a | chr14:20667443-20667454 |
13 | CEBPB | chr14:20683369-20683682 | IMR90 | lung: | n/a | chr14:20683523-20683534 |
14 | CEBPB | chr14:20683376-20683687 | A549 | lung: | n/a | chr14:20683523-20683534 |
15 | CEBPB | chr14:20668546-20668738 | A549 | lung: | n/a | n/a |
16 | CEBPB | chr14:20659170-20659372 | K562 | blood: | n/a | chr14:20659228-20659241 chr14:20659229-20659240 chr14:20659227-20659244 |
17 | CEBPB | chr14:20683431-20683747 | MCF-7 | breast: | n/a | chr14:20683523-20683534 |
18 | CHD2 | chr14:20662444-20662449 | GM12878 | blood: | n/a | n/a |
19 | CTCF | chr14:20693400-20693550 | HepG2 | liver: | n/a | n/a |
20 | CTCF | chr14:20685100-20685250 | GM12864 | blood: | n/a | n/a |
21 | CTCF | chr14:20669388-20669474 | MCF-7 | breast: | n/a | n/a |
22 | CTCF | chr14:20664213-20664339 | HepG2 | liver: | n/a | n/a |
23 | CTCF | chr14:20664078-20664471 | K562 | blood: | n/a | n/a |
24 | CTCF | chr14:20664260-20664410 | BE2_C | brain: | n/a | n/a |
25 | CTCF | chr14:20693380-20693530 | A549 | lung: | n/a | n/a |
26 | CTCF | chr14:20664169-20664172 | LNCaP | prostate: | n/a | n/a |
27 | CTCF | chr14:20664241-20664344 | ProgFib | skin: | n/a | n/a |
28 | CTCF | chr14:20685140-20685290 | GM12864 | blood: | n/a | n/a |
29 | CTCF | chr14:20664220-20664370 | Hela-S3 | cervix: | n/a | n/a |
30 | CTCF | chr14:20685180-20685330 | AG10803 | skin: | n/a | n/a |
31 | CTCF | chr14:20685200-20685350 | SAEC | small airway: | n/a | n/a |
32 | CTCF | chr14:20663911-20664541 | SK-N-SH | brain: | n/a | n/a |
33 | CTCF | chr14:20685300-20685338 | MCF-7 | breast: | n/a | n/a |
34 | CTCF | chr14:20685225-20685399 | A549 | lung: | n/a | n/a |
35 | CTCF | chr14:20685218-20685434 | A549 | lung: | n/a | n/a |
36 | CTCF | chr14:20685185-20685468 | K562 | blood: | n/a | n/a |
37 | CTCF | chr14:20664173-20664381 | LNCaP | prostate: | n/a | n/a |
38 | CTCF | chr14:20685100-20685250 | GM12868 | blood: | n/a | n/a |
39 | CTCF | chr14:20685288-20685357 | Gliobla | brain: | n/a | n/a |
40 | CTCF | chr14:20664001-20664467 | MCF-7 | breast: | n/a | n/a |
41 | CTCF | chr14:20693420-20693570 | A549 | lung: | n/a | n/a |
42 | CTCF | chr14:20664209-20664369 | MCF-7 | breast: | n/a | n/a |
43 | CTCF | chr14:20664148-20664387 | K562 | blood: | n/a | n/a |
44 | CTCF | chr14:20664182-20664339 | SK-N-SH_RA | brain: | n/a | n/a |
45 | CTCF | chr14:20685238-20685511 | K562 | blood: | n/a | n/a |
46 | CTCF | chr14:20664248-20664331 | Fibrobl | skin: | n/a | n/a |
47 | CTCF | chr14:20664180-20664330 | HRPEpiC | eye: | n/a | n/a |
48 | CTCF | chr14:20664184-20664356 | Hela-S3 | cervix: | n/a | n/a |
49 | CTCF | chr14:20685338-20685353 | GM12891 | blood: | n/a | n/a |
50 | CTCF | chr14:20693369-20693508 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:20664021-20664071 | ProgFib | skin: | n/a |
2 | chr14:20691777-20691827 | HepG2 | liver: | n/a |
3 | chr14:20704361-20704411 | K562 | blood: | n/a |
4 | chr14:20664021-20664071 | Jurkat | blood: | n/a |
5 | chr14:20666088-20666138 | IMR90 | lung: | fetal |
6 | chr14:20691777-20691827 | SK-N-MC | brain: | n/a |
7 | chr14:20664021-20664071 | HPAEpiC | pulmonary alveolar: | n/a |
8 | chr14:20704361-20704411 | RPTEC | kidney: | n/a |
9 | chr14:20664021-20664071 | IMR90 | lung: | fetal |
10 | chr14:20666088-20666138 | NB4 | blood: | n/a |
11 | chr14:20664021-20664071 | HAEpiC | amniotic membrane: | n/a |
12 | chr14:20664580-20664630 | PFSK-1 | brain: | n/a |
13 | chr14:20664021-20664071 | AG10803 | skin: | n/a |
14 | chr14:20664580-20664630 | GM12891 | blood: | n/a |
15 | chr14:20666088-20666138 | HIPEpiC | eye: | n/a |
16 | chr14:20692622-20692672 | PANC-1 | pancreas: | n/a |
17 | chr14:20666088-20666138 | GM12891 | blood: | n/a |
18 | chr14:20692622-20692672 | SAEC | small airway: | n/a |
19 | chr14:20691777-20691827 | NH-A | brain: | n/a |
20 | chr14:20666088-20666138 | BE2_C | brain: | n/a |
21 | chr14:20704361-20704411 | NHDF-neo | bronchial: | n/a |
22 | chr14:20691777-20691827 | U87 | brain: | n/a |
23 | chr14:20691777-20691827 | HCM | heart: | n/a |
24 | chr14:20692622-20692672 | Jurkat | blood: | n/a |
25 | chr14:20666088-20666138 | AG04450 | lung: | fetal |
26 | chr14:20704361-20704411 | HCM | heart: | n/a |
27 | chr14:20664580-20664630 | NHBE | bronchial: | n/a |
28 | chr14:20664021-20664071 | NB4 | blood: | n/a |
29 | chr14:20704361-20704411 | ovcar-3 | ovarian: | n/a |
30 | chr14:20704361-20704411 | PANC-1 | pancreas: | n/a |
31 | chr14:20691777-20691827 | Caco-2 | colon: | n/a |
32 | chr14:20692622-20692672 | AG09319 | gingival: | n/a |
33 | chr14:20664021-20664071 | SK-N-SH | brain: | n/a |
34 | chr14:20664580-20664630 | SK-N-SH | brain: | n/a |
35 | chr14:20664580-20664630 | NT2-D1 | testis: | n/a |
36 | chr14:20666088-20666138 | GM12892 | blood: | n/a |
37 | chr14:20691777-20691827 | HIPEpiC | eye: | n/a |
38 | chr14:20704361-20704411 | HL-60 | blood: | n/a |
39 | chr14:20666088-20666138 | GM19239 | blood: | n/a |
40 | chr14:20691777-20691827 | Hepatocyte | liver: | n/a |
41 | chr14:20664021-20664071 | MCF10A-Er-Src | breast: | n/a |
42 | chr14:20664021-20664071 | U87 | brain: | n/a |
43 | chr14:20691777-20691827 | HAEpiC | amniotic membrane: | n/a |
44 | chr14:20666088-20666138 | Jurkat | blood: | n/a |
45 | chr14:20664580-20664630 | AG09309 | skin: | n/a |
46 | chr14:20704361-20704411 | HIPEpiC | eye: | n/a |
47 | chr14:20666088-20666138 | HepG2 | liver: | n/a |
48 | chr14:20704361-20704411 | HMEC | breast: | n/a |
49 | chr14:20692622-20692672 | ProgFib | skin: | n/a |
50 | chr14:20666088-20666138 | U87 | brain: | n/a |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:20657790..20659854-chr14:20660139..20662743,2 | K562 | blood: | |
2 | chr14:20691139..20693631-chr14:20695657..20698105,2 | K562 | blood: | |
3 | chr14:20691139..20693631-chr14:20695657..20698105,2 | K562 | blood: | |
4 | chr14:20653650..20655621-chr14:20656798..20658985,2 | K562 | blood: | |
5 | chr14:20657790..20659854-chr14:20660139..20662743,2 | K562 | blood: | |
6 | chr14:20674085..20677001-chr14:20687478..20690164,2 | MCF-7 | breast: | |
7 | chr14:20674085..20677001-chr14:20687478..20690164,2 | MCF-7 | breast: | |
8 | chr14:20653449..20656373-chr14:20661305..20663533,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR11H5P | TF binding region |
ENSG00000266336 | TF binding region |
OR11G2 | TF binding region |
OR11H6 | TF binding region |
OR11H4 | TF binding region |
OR11H7 | TF binding region |
OR11H5P | CpG island |
ENSG00000266336 | CpG island |
OR11G2 | CpG island |
OR11H6 | CpG island |
OR11H4 | CpG island |
OR11H7 | CpG island |
ENSG00000176219 | chromatin interactions |
ENSG00000258806 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376457551 | chr14:20661259-20661260 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs2318884 | chr14:20661292-20661293 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs565895514 | chr14:20662325-20662326 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs183363700 | chr14:20662333-20662334 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs8016235 | chr14:20662371-20662372 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs569262113 | chr14:20662471-20662472 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs74033842 | chr14:20662534-20662535 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs555381396 | chr14:20662535-20662536 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs568656261 | chr14:20662538-20662539 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs558432898 | chr14:20663224-20663225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550929292 | chr14:20663227-20663228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543926769 | chr14:20663237-20663238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151170450 | chr14:20663245-20663246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141030057 | chr14:20663267-20663268 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs542748416 | chr14:20663304-20663305 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs374455966 | chr14:20663402-20663403 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs189534616 | chr14:20663404-20663405 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs111303488 | chr14:20663420-20663421 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs150249769 | chr14:20663465-20663466 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs138911393 | chr14:20663474-20663475 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs575965227 | chr14:20663515-20663516 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs563170626 | chr14:20663530-20663531 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs530503375 | chr14:20663538-20663539 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs549075915 | chr14:20663551-20663552 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs142226283 | chr14:20663585-20663586 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs145915794 | chr14:20663606-20663607 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs547735236 | chr14:20663607-20663608 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs566369009 | chr14:20663628-20663629 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs540184737 | chr14:20663631-20663632 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs551984859 | chr14:20663642-20663643 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs570296102 | chr14:20663733-20663734 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs543028043 | chr14:20663756-20663757 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs550497979 | chr14:20663901-20663902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537115758 | chr14:20663905-20663906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555852185 | chr14:20663921-20663922 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs573906074 | chr14:20663947-20663948 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs535007609 | chr14:20664021-20664022 | Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs377690801 | chr14:20664025-20664026 | Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs180676459 | chr14:20664098-20664099 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs544936867 | chr14:20664130-20664131 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs116756762 | chr14:20664163-20664164 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs116866510 | chr14:20664165-20664166 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs184018430 | chr14:20664167-20664168 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs138175391 | chr14:20664176-20664177 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs561045954 | chr14:20664200-20664201 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs528216614 | chr14:20664214-20664215 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs546573950 | chr14:20664215-20664216 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs564904000 | chr14:20664225-20664226 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs567545508 | chr14:20664241-20664242 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs1953554 | chr14:20664258-20664259 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cone-rod dystrophy | 18421352 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 21482944 | CNVD |
Mental retardation | 19951919 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Ependymoma | 20639864 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:20663200-20664600 | Enhancers | K562 | blood |
2 | chr14:20664200-20666400 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
3 | chr14:20665600-20666400 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr14:20665800-20666400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr14:20677600-20678400 | Enhancers | K562 | blood |
6 | chr14:20686000-20687200 | Enhancers | A549 | lung |
7 | chr14:20687000-20687200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
8 | chr14:20687000-20687200 | Enhancers | K562 | blood |
9 | chr14:20687000-20687400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr14:20687000-20687600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr14:20687200-20687400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr14:20687200-20687800 | Flanking Active TSS | A549 | lung |
13 | chr14:20687200-20687800 | Enhancers | Hela-S3 | cervix |
14 | chr14:20687200-20687800 | Flanking Active TSS | K562 | blood |
15 | chr14:20687400-20687600 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
16 | chr14:20687600-20687800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
17 | chr14:20687800-20688200 | Enhancers | A549 | lung |
18 | chr14:20687800-20691200 | Weak transcription | K562 | blood |
19 | chr14:20691200-20692600 | Enhancers | K562 | blood |
20 | chr14:20695400-20695600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
21 | chr14:20698000-20698400 | Active TSS | Fetal Heart | heart |
22 | chr14:20704000-20704400 | Active TSS | HepG2 | liver |
23 | chr14:20707000-20707200 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |